» Articles » PMID: 28507980

Hypertension in the Pediatric Kidney Transplant Recipient

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2017 May 17
PMID 28507980
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension after kidney transplant is a frequent occurrence in pediatric patients. It is a risk factor for graft loss and contributes to the significant burden of cardiovascular disease (CVD) in this population. The etiology of posttransplant hypertension is multifactorial including donor factors, recipient factors, medications, and lifestyle factors similar to those prevalent in the general population. Ambulatory blood pressure monitoring has emerged as the most reliable method for measuring hypertension in pediatric transplant recipients, and many consider it to be essential in the care of these patients. Recent technological advances including measurement of carotid intima-media thickness, pulse wave velocity, and myocardial strain using specked echocardiography and cardiac magnetic resonance imaging have improved our ability to assess CVD burden. Since hypertension remains underrecognized and inadequately treated, an early diagnosis and an appropriate control should be the focus of therapy to help improve patient and graft survival.

Citing Articles

Supporting Transgender, Nonbinary, and Gender Diverse Youth During Solid Organ Transplantation.

Alexander K, Goodall J, Allen B Pediatr Transplant. 2024; 29(1):e14864.

PMID: 39620485 PMC: 11610667. DOI: 10.1111/petr.14864.


Hypertension monitoring on cardiac health outcomes.

Subhash S, Satariano M, Doshi K, Bhatt G, Raina R Transl Pediatr. 2024; 13(3):518-524.

PMID: 38590375 PMC: 10998995. DOI: 10.21037/tp-23-527.


Post-transplant education for kidney recipients and their caregivers.

Singer P Pediatr Nephrol. 2022; 38(7):2033-2042.

PMID: 36227432 DOI: 10.1007/s00467-022-05744-6.


Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden.

Reggiani F, Moroni G, Ponticelli C J Pers Med. 2022; 12(8).

PMID: 35893294 PMC: 9329988. DOI: 10.3390/jpm12081200.


The Pathology Lesion Patterns of Podocytopathies: How and why?.

Ravaglia F, Melica M, Angelotti M, De Chiara L, Romagnani P, Lasagni L Front Cell Dev Biol. 2022; 10:838272.

PMID: 35281116 PMC: 8907833. DOI: 10.3389/fcell.2022.838272.


References
1.
Virga G, Stomaci B, Munaro A, Mastrosimone S, Cara M, Artuso E . Systolic and diastolic function in renal replacement therapy: a cross-sectional study. J Nephrol. 2006; 19(2):155-60. View

2.
London G, Marchais S, Guerin A . Arterial stiffness and function in end-stage renal disease. Adv Chronic Kidney Dis. 2004; 11(2):202-9. DOI: 10.1053/j.arrt.2004.02.008. View

3.
Gossmann J, Radounikli A, Bernemann A, Schellinski O, Raab H, Bickeboller R . Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?. Kidney Blood Press Res. 2001; 24(2):111-5. DOI: 10.1159/000054216. View

4.
Mitsnefes M, Khoury P, McEnery P . Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr. 2003; 143(1):98-103. DOI: 10.1016/S0022-3476(03)00209-9. View

5.
Chan M, Patwardhan A, Ryan C, Trevillian P, Chadban S, Westgarth F . Evidence-based guidelines for the nutritional management of adult kidney transplant recipients. J Ren Nutr. 2011; 21(1):47-51. DOI: 10.1053/j.jrn.2010.10.021. View